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Neural Stem Cells (NSCs) and Proteomics*
Lorelei D. Shoemaker‡ and Harley I. Kornblum§¶
Neural stem cells (NSCs) can self-renew and give rise to
the major cell types of the CNS. Studies of NSCs include
the investigation of primary, CNS-derived cells as well as
animal and human embryonic stem cell (ESC)-derived and
induced pluripotent stem cell (iPSC)-derived sources.
NSCs provide a means with which to study normal neural
development, neurodegeneration, and neurological dis-
ease and are clinically relevant sources for cellular repair
to the damaged and diseased CNS. Proteomics studies of
NSCs have the potential to delineate molecules and path-
ways critical for NSC biology and the means by which
NSCs can participate in neural repair. In this review, we
provide a background to NSC biology, including the
means to obtain them and the caveats to these pro-
cesses. We then focus on advances in the proteomic
interrogation of NSCs. This includes the analysis of post-
translational modifications (PTMs); approaches to analyz-
ing different proteomic compartments, such the secre-
tome; as well as approaches to analyzing temporal
differences in the proteome to elucidate mechanisms of
differentiation. We also discuss some of the methods that
will undoubtedly be useful in the investigation of NSCs but
which have not yet been applied to the field. While many
proteomics studies of NSCs have largely catalogued the
proteome or posttranslational modifications of specific
cellular states, without delving into specific functions,
some have led to understandings of functional processes
or identified markers that could not have been identified
via other means. Many challenges remain in the field,
including the precise identification and standardization of
NSCs used for proteomic analyses, as well as how to
translate fundamental proteomics studies to functional
biology. The next level of investigation will require inter-
disciplinary approaches, combining the skills of those in-
terested in the biochemistry of proteomics with those
interested in modulating NSC function. Molecular &
Cellular Proteomics 15: 10.1074/mcp.O115.052704, 344–
354, 2016.
Neural stem cells, which are present both during develop-
ment and in the adult, are most commonly defined by the
ability to self-renew and the capacity to generate the major
cell types in the central nervous system (CNS)1, including
oligodendrocytes, astrocytes, and neurons. Within this seem-
ingly simple definition, however, the diversity of what is
termed “neural stem cells” is quite large. There is a broad
spectrum of NSCs with varying degrees of potency from
multi- to more limited progenitors, each with unique lineages,
fates, and spatial and temporal molecular signatures, that
ultimately give rise to the vast numbers of mature CNS cell
types (1–5). In this review, the term “NSC” will be used to
generally describe this heterogeneous family of neural stem
and progenitor cells. The study of NSCs has led to major
advances in neural development and also to the vision of
therapeutic uses in neurodegeneration, disease, and aging.
While the first evidence of proliferating cells within the hu-
man brain was found in the 1800s, the age of NSC studies
began in earnest in the 1990s with the development of ad-
vanced techniques, including approaches to isolation and
purification, in vitro models, lineage tracing, and molecular
profiling (historical review (6)). As illustrated in Fig. 1, there are
currently three primary means of obtaining NSCs: (1) direct
isolation from the developing or adult CNS using a variety of
markers; (2) amplification of isolated cells in vitro; and (3)
directed differentiation from pluripotent cells consisting of
either embryonic stem cells (ESCs) or induced pluripotent
stem cells (iPSCs). Each of these approaches to isolation or
enrichment comes with its own drawbacks. Ideally, all studies
would use bona fide NSCs purified from in vivo sources.
However, despite a great deal of effort, there are no protein
markers that absolutely purify even one type of NSCs, per-
haps a reasonable finding given NSC diversity. On the other
hand, any tissue culture method being used will introduce
both heterogeneity as well as tissue culture artifacts.
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The first neural stem cells identified were in vitro models
isolated from embryonic rat forebrain (7) and adult mouse
brain (8). However, CNS-derived NSCs have now been ob-
tained from a multitude of developmental stages and brain
regions, including spinal cord, grown in vitro as attached or
floating cultures, and exist as both primary and established
cell lines (Figs. 1C, 1D, and 1E) (8–11). The isolation of pluri-
potent embryonic stem cells (ESCs) from mice (12, 13) and
from humans (14) ushered in a new era for the field and has
led to novel approaches to drive ESCs to a NSC fate (Fig. 1A)
(15–17). Advances in understanding the maintenance of ESC
pluripotency led directly to the manipulation of key molecules
associated with ESC pluripotency, in particular octamer-bind-
ing transcription factor 4 (OCT4), (sex determining region
Y)-box 2 (SOX2), Kruppel-like factor 4 (KFL4), and the tran-
scription factor, c-MYC, to generate pluripotent iPSCs from
fully differentiated somatic cells (18, 19). Approaches to gen-
erating iPSCs have evolved since the initial description and
now include many innovations and much diversity in method-
ologies, including various cocktails of transcription factors,
transcription factor delivery options, xeno-free cultures, and
nonintegrating approaches (20) (reviewed in (21)). The gener-
ation of human iPSCs has led to technological advances in
the study of NSCs (Fig. 1B) (22–24) and has had important
implications for the realization of effective therapies, as sig-
nificant differences exist between human and animal NSCs
and disease.
Utility of NSCs—With the lofty goal of neural repair, there is
clear potential for clinical uses of NSCs, either through trans-
plantation of NSCs, of more committed cell types, of autolo-
gous iPSC-derived cells, or of manipulation of endogenous
stem cells in vivo, for diseases ranging from ALS, Parkinson’s
disease, spinal cord injury, and stroke (reviewed in (25)). In the
initial approaches of NSCs for use in neural repair, investiga-
tors were primarily focused on discovering the means to
direct cell fate in a general fashion: that is, to guide cells to
become either neurons, astrocytes or oligodendrocytes, or, at
best, to guide cells to synthesize a specific neurotransmitter,
such as dopamine for Parkinson’s disease. Despite decades
of successful research in the field (26, 27), many questions
remain, including what defines NSCs molecularly, how this
signature may be manipulated to produce certain cell types,
how similar NSCs are when derived from different sources,
what are the primary signaling pathways, master transcrip-
tional controls, key protein posttranslational modifications
and epigenetic changes, and what drives cell specification
and differentiation in vitro and in vivo? However, as the knowl-
FIG. 1. Illustration of the primary means of obtaining neural stem cells (NSCs). Pluripotent stem cells such as (A) embryonic stem cells
(ESCs) obtained from the blastocyst or (B) induced pluripotent stem cells (iPSCs) derived from mature somatic cells can be directed to a neural
stem cell fate in culture to generate NSCs. NSCs can also be isolated directly from (C) the developing neural tube, (D) the developing nervous
system, or (E) from the adult CNS. The type of NSCs obtained is a function of both in vivo regional and temporal aspects as well as the in vitro
environment the cells experience, as represented by the varying color and shape of the NSCs. CNS: central nervous system; SC: spinal cord.
Not drawn to scale.
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edge of developmental biology and the technology of repro-
gramming have grown, simplistic approaches have given way
to attempts to direct general cell fate in a more specific
fashion. For instance, although clinical studies of differenti-
ated iPSCs are in their infancy, a recent report detailed the
transplantation of cortically fated neuronal progenitors de-
rived from human iPSCs, resulting in mature, functional cor-
tical neurons and functional recovery in a rodent stroke model
(28). By being more sophisticated in (re)programming specific
progenitors or cell types and by providing a finer molecular
definition of those cells, we may be in a better position to
affect and direct clinical outcomes, to improve efficacy and
safety for future transplantation.
A major challenge lies in the understanding of the mecha-
nisms of action of NSC transplants. It is unclear how NSC
treatments might exert their benefit—will they be capable of
generating complex circuitry, or will their effects be to provide
general support for endogenous repair mechanisms? The
existing theories for potential benefit of NSCs include the
delivery of trophic support to the injured tissue, increased
host cell survival, provision of immunomodulation, contribu-
tions to angiogenesis, and integration into the host tissue to
provide cellular scaffolding and re-establishing synapses and
neural circuits. To understand the in vivo consequences of
NSC transplants, technological advances are necessary to
address for instance the difficult task of distinguishing host
versus donor tissue. In recent elegant work, Kumamaru et al.
describe the in vivo isolation and RNA-seq profile of mouse
spinal cord derived neural stem/progenitor cells (NSPCs) from
host tissue following transplantation into a spinal cord injury
model (29). This type of study has yet to be accomplished at
the level of the proteome with current proteomics ap-
proaches, and remains a technological challenge.
Importantly, NSC research was previously dominated pri-
marily by rodent-derived stem cells, but human ESC and in
particular human iPSC technology has led to an increase in
human-derived stem cell studies. iPSC technologies are in-
creasingly being utilized to develop “disease-in-dish” ap-
proaches using patient-derived cells, offering a significantly
more “human,” albeit in vitro, environment and have been
used to study diseases as diverse as epilepsy, Huntington’s
disease, schizophrenia, and Parkinson’s disease (reviewed in
(30) and covered in greater detail in this special issue of MCP).
Neural Stem Cell Biology—Although a detailed review of
NSC biology is beyond the scope of this review, we will briefly
cover some basics to illustrate the diversity of NSCs present
throughout development. The purpose here is to familiarize
the nonexpert reader, who may be interested in interrogating
NSC with proteomics, with the basics of the field. During
embryonic and fetal development, NSCs are found through-
out the neuraxis in specialized pseudostratified columnar neu-
roepthelium lining the surfaces of the developing ventricular
system and central canal. During these stages, NSCs express
the intermediate filament, nestin (31), and the extracellular
protein, Lex/SSEA1/CD15 (32) and have a high proliferative
and neuronogenic capacity. These cells are, in fact, radial glia
(33), long thought to be mere scaffolds for neuronal migration,
and have attachments extending from the ventricular to the
pial (or outer) surfaces. As development proceeds, in most
CNS regions, the ventricular zone thins. However, in the fore-
brain, some NSCs detach from the ventricular surface to form
the subventricular zone, which then gives rise to an additional,
even more superficial zone termed the outer radial glia zone
(34), which also contains NSCs. Over the course of develop-
ment within most brain regions, NSCs are first predominantly
neuronogenic, generating primarily neurons, and later be-
come largely gliogenic, a pattern that holds to some extent in
vitro, with earlier derived NSCs giving rise mainly to neurons
and later ones primarily to glia (35). During this time, NSCs
generally switch their intermediate filament expression from
nestin to glial fibrillary acidic protein (36–38) and are occa-
sionally termed astrocytes, although astrocytes located in the
parenchyma, away from these germinal zones do not have the
characteristics of NSCs. In the adult mammalian brain, glial
fibrillary acidic protein-positive NSCs are located in a thin
subventricular zone as well as in the hippocampus, where
they give rise to new granule cells that participate in the
formation of certain memories (37). In the forebrain subven-
tricular zone lining the lateral ventricle, NSCs give rise to
olfactory bulb neurons that may participate in certain forms of
olfactory learning and memory (39), although it is not clear
whether this is the case in humans, as at least some subven-
tricular zone NSCs participate in the genesis of neurons in the
adjacent caudate nucleus (40).
In addition to these well-known NSC locations and sources,
there are other, more poorly understood or less well-known
regions harboring neural stem cells. Though controversial,
there is a growing body of evidence suggesting that in some
brain regions, ependymal cells (specialized ciliated cells lining
the ventricular surfaces) also function as NSCs (41, 42). Fur-
thermore, prior to the appearance of definitive, nestin-ex-
pressing neural stem cells, more primitive neural stem cells
exist that have the capacity to give rise to neural stem cells
but also may produce nonneural lineages when injected into
blastocysts (43). Additionally, there are multipotent neural
progenitors located at the surface of the cortex, in the mar-
ginal zone, far removed from the traditional germinal zones
during development (44).
NSCs from different brain regions and developmental
stages possess distinct characteristics, as illustrated in Figs
1C-1E. This includes intrinsic neuronogenic and gliogenic
capacity but also dorsal-ventral patterning signatures and
many other qualities. Furthermore, within a distinct brain re-
gion, there may be multiple types of cells with the character-
istics of NSC self-renewal and multipotency. Indeed, the act
of placing cells in culture may obscure some of these differ-
ences. For example, oligodendrocytes are normally specified
from select brain regions during development, but in vitro, all
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NSCs are capable of giving rise to oligodendrocytes. To fur-
ther complicate the situation, cells that behave only as short-
term progenitors in vivo may behave as long-, self-renewing
NSCs in vitro(45).
NSC Methodologies—There has been a large effort to de-
velop reliable systems to purify neural stem cells from living
tissue for biochemical analysis. Early research focused on
standard FACS methodologies using combinations of cell size
and protein expression (46) as well as dye exclusion based on
expression of ABC transporters (47). Other strategies have
included the use of promoter-specific expression (48, 49) or
extracellular markers such as 3-fucosyl-N-acetyl-lactosamine
(or SSEA1, CD15, or LeX) (50) in mice and prominin1 (or
CD133) in humans (51). These methods, while producing
some degree of enrichment, have not necessarily resulted in
the isolation of a pure stem cell fraction. More recently, inves-
tigators have used a combination of methods, including trans-
genic mice and extracellular promoters to provide a greater
level of enrichment (52, 53). Even given these improvements,
obtaining sufficient quantities of a pure population of NSCs
for a comprehensive proteomic study can present significant
challenges.
NSCs can be cultured in a variety of ways. They can be
easily propagated from the developing and adult CNS using a
simple serum-free medium supplemented with basic fibro-
blast growth factor (FGF) and/or epidermal growth factor
(EGF). In early rodent embryonic development, isolated NSCs
respond only to basic fibroblast growth factor and not to EGF,
although postnatally derived NSCs respond to both (54).
NSCs can be cultured as nonattached neurospheres (NS) or
as adherent monolayers and can now be derived from both
the developing and adult human CNS, although the survival
and growth of adult NSCs are improved with the addition of
leukemia inhibitory factor (55). The culturing of NSCs can
greatly expand the numbers of cells for subsequent studies,
but under no circumstances are these cultures homogeneous.
To partially mitigate this, comparative studies involving, for
instance, proliferating cultures with those induced to differen-
tiate are a valuable approach. We have taken advantage of
this contrast to examine both mRNA (56) and protein expres-
sion (57) in NSCs, identifying genes and proteins with roles in
NSC biology such as maternal embryonic leucine zipper ki-
nase (MELK), t-lak cell-originated protein kinase (TOPK). and
the netrin/repulsive guidance molecule (RGM) receptor,
neogenin.
The strength of using in vitro systems may lie in the ability
to model human development and disease. Therefore, a great
deal of effort has been placed in the development of regional
and cell-type specific production of neural progenitors from
human pluripotent stem cells. Human pluripotent stem cells
(ESC and iPSC) can serve as a reservoir to generate large
numbers of NSCs. Recent years have seen an explosion in the
methodologies to accomplish this. ESCs can be manipulated
via a myriad of morphogens to produce a variety of types of
NSCs, including spinal motor progenitors, cerebral cortical
excitatory and inhibitory neuronal progenitors, midbrain do-
pamine progenitors, and glial progenitors. Obtaining large
numbers of progenitors from mouse ESCs is relatively rapid
and easy. Most protocols now involve generation of floating
embryoid bodies followed by replating until they form neural
“rosettes,” structures that bear some resemblance to the
neural tube (58, 59). The rosettes, which contain the primitive
NSC-like cell described above, are then manually picked,
replated, and ultimately propagated as NSCs. Using these
fundamental methods, the production of various types of
neurons can be manipulated using specific factors to direct
this differentiation. For example, there are factors that cau-
dalize and ventralize the NSCs to produce those with the
characteristics of spinal cord motor neurons (60). Interest-
ingly, apparent cerebral cortical stem cells and then cortical
excitatory neurons can be generated simply by omission of
these caudalizing or ventralizing signals (61). The drawbacks
to using any of these in vitro methods, again includes the
heterogeneity of the cultures and, in the case of human cells,
the considerable time and expense required to produce suf-
ficient numbers of cells for subsequent analyses. Another
drawback to the process lies in the lack of complete knowl-
edge as to how the developmental stage of pluripotent stem
cell-generated NSCs and their progeny correspond to those
of the true CNS in vivo. A great deal of effort is now being
placed on developing tools to ascertain this relationship (62,
63); however, the continuing development of methodologies
to derive region-specific NSCs will allow greater accuracy and
relevance of all “omics” studies, including those of proteom-
ics. In addition, as limits of detection for proteomics and other
“omics” studies continue to improve, the amount of starting
material required for various analyses continues to decrease,
enabling the interrogation of smaller populations of cells.
Interrogating NSCs—Why Proteomics?—Numerous stud-
ies have investigated the transcriptomics of neural stem cells
and the process of neural stem cell differentiation and cell
fate, an example of which is described above, in which we
used differential mRNA expression to identify key regulators
of neural stem cell proliferation (56). These studies have con-
tributed to the understanding of many facets of neural stem
cell biology and have identified key regulators of neural stem
cell function. While RNA-based approaches have a large part
to play in delineating the roles of specific proteins in neural
stem cell function, there is an important role for proteomics to
play as well. Not only do proteomics studies help to provide a
“fuller” picture of the actual state of cells than does simple
mRNA profiling, because gene expression does not always
correlate with protein expression (64), but there are also im-
portant facets of neural stem cell biology that can really only
be fully ascertained by proteomic analyses. Proteomics stud-
ies are particularly well-suited to identify markers of NSC in all
their varying forms, as well as to identify secreted proteins
that endogenous and transplanted neural stem cells may
Proteomics of Neural Stem and Progenitor Cells
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produce. Also, since many of the pathways involved in cell
fate determination are activated or inhibited by posttransla-
tional modifications such as phosphorylation or ubiquitina-
tion, it is only through proteomics studies that we will gain an
understanding of these processes. Furthermore, proteomics
analyses can be used to determine subcellular localizations of
proteins, information that can only be partially inferred from
RNA-based methods. Excellent reviews on various aspects of
stem cell proteomics have been recently published (65–67).
In the following sections, we have highlighted a number of
studies to illustrate the potential of proteomics to address the
main questions of characterization of the proteins of NSCs,
the location of those proteins in NSCs, protein expression
changes over time and with differentiation, and finally, the
molecular differences between NSCs and their parents and
progeny. While the studies presented demonstrate a start, the
field is still in its infancy and few studies have made the jump
from cataloguing proteins to analyzing function. A great deal
more research is needed to bring proteomics to the forefront
of NSC research.
Characterization of NSC Protein Expression—Some of the
first studies to establish protein signatures of various NSCs
addressed the very basic but essential question of the com-
position of these cells and often used the most available
platforms—2 dimensional gel electrophoresis (DGE) and
MALDI-TOF MS—to analyze, for instance, rat hippocampal
NSCs (68) or a human NSC line (69). At the time, MS ap-
proaches were an emerging technology with 500–1,200 pro-
teins detected and anywhere from 200–400 actually identi-
fied. Seemingly continual advances in separation technology,
label-based or label-free quantitation, single or multiple reac-
tion monitoring, detection, instrumentation, and software
have led to a massive leap in the number of proteins observed
and confidently identified—routinely surpassing thousands in
one experiment—and it is estimated that greater than 90% of
the human proteome has now been defined according to
ProteomicsDB (70). The result is a vast improvement on the
“resolution” of the proteome profile (for an overview see (71,
72)).
Posttranslational modifications (PTMs) are an important
component of NSC characterization and provide insight into
cellular signaling, differentiation, and maintenance. MS is par-
ticularly amenable to the large-scale analysis of PTMs, mod-
ifications that are not easily predicted by other techniques,
particularly as advanced PTM enrichment strategies are de-
veloped, as proteome coverage is increased, and as MS
techniques advance (reviewed in (73)). Phosphorylation, gly-
cosylation, acetylation, and ubiquitination are some of the
more common PTMs, but there are well over 300 different
types of PTMs, including those affecting epigenetic changes
such as acetylation and methylation modifications of histones
(reviewed in (67, 74)). Despite the technological challenges of
large-scale PTM studies, often including the reliance on PTM
enrichment, there has been a number of key studies. Differ-
ences in the phosphoproteomes of human undifferentiated
and retinoic acid (RA)-differentiated (neuralized) ESCs were
identified and resulted in the identification of hundreds of
proteins with unique phosphorylation (75). There were multi-
ple altered signaling pathways as ESCs acquired a neural fate
following treatment with RA, including a previously unde-
scribed role for the JNK pathway. To gain insight into global
ubiquitination—termed the “ubiquitome”—Buckley et al. used
stable isotope labeling by amino acids in cell culture (SILAC)
and ubiquitinated peptide enrichment to identify modified pro-
teins from RA-mediated differentiated and pluripotent mouse
ESCs and iPSCs (76). The authors identified 17 genes that
regulated ESC differentiation toward a neural fate, three of
which they validated (Fbxw7, Socs3, and RNF31). In a major
effort to understand the quantitative changes in the mem-
brane proteome during differentiation of human ESCs to
NSCs, Nunes Melo-Braga and colleagues isolated mem-
brane-bound proteins from both cell populations, further iden-
tified specific multi- and mono-phosphorylation and sialic
acid N-linked glycosylation PTMs, and validated several pro-
teins with modified sites by selected reaction monitoring (77).
In addition to providing a wealth of data on membrane-bound
proteins, including the identification of novel potential surface
markers of NSCs such as Crumbs 2 (which was up-regulated
at the both the proteome and sialiome levels), this group
identified unique glycosylation patterns in both cell popula-
tions and highlighted the potential importance of sialylated
glycoproteins in the definition of the stem cell state.
In an extension of this approach to examine multiple PTMs,
PTM “crosstalk” is a growing field that focuses not on global
PTMs but rather where the PTMs are occurring on the protein
and how these PTMs relate to each other to alter downstream
events such as signaling or transcription (reviewed in (78)).
While this has yet to be applied to NCSs on a large scale, an
example of how such a method might be used is provided by
Jung et al. who used weak cation exchange and hydrophilic
interaction liquid chromatography to separate 5–6 kDa N-ter-
minal tail H3 histone peptides from mouse ESCs followed by
high mass accuracy electron transfer dissociation MS/MS to
identify 114 peptides with unique H3 methylation, acetylation,
and phosphorylation patterns (79). They went on to produce a
combinatorial map of the histone PTM landscape that may
potentially be ESC-specific, thereby gaining insight into the
pluripotent state.
Comparative Expression—To develop a greater under-
standing of the mechanisms underlying NSC biology and to
address heterogeneity in NSC populations, many studies
have focused on identifying differentially expressed proteins
or PTMs. Earlier studies relied on 2DGE methodology as a
means to compare samples, as was the case to identify
membrane-associated proteins that may play a role in main-
taining a more potent state in the mouse embryonic NSPCs as
compared with those isolated from the postnatal brain (57).
The development of protein labeling techniques, in particular
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SILAC and isobaric tags such as iTRAQ, has allowed mass
spectrometry to enter the realm of relative and absolute quan-
tification. This was demonstrated in the use of SILAC to
compare the proteome and phosphoproteome of two human
ESC lines, as well as the complement of membrane proteins
specific to undifferentiated and to spontaneously differenti-
ated ESCs upon removal of FGF (80). The group identified six
membrane proteins specifically up-regulated in hESCs, in-
cluding Prominin-1(a known ESC marker) and Neuroligin-4,
and 17 membrane proteins whose expression was increased
during differentiation that included matrix metallopeptidase
(MMP)-14 and Semaphorin 4A. While the ESCs were nonspe-
cifically differentiated to NSCs in this study, using this ap-
proach in a more detailed differentiation of ESCs along the
neural lineage could provide additional membrane protein
candidates that could be used for subsequent purification of
subsets of neural-fated progenitors. To address a clinically
relevant question regarding the differences between mo-
toneurons (MN) derived from iPSCs and from ESCs, Toma et
al. used FACS to purify MN generated from both iPSCs and
ESCs that expressed green fluorescent protein under a mo-
toneuron promoter, Hb9 (81). Using a label-free LC-MS/MS
analysis, they identified 3,025 proteins, 50 of which were
unique to iPSCMNs and 93 to ESCMNs, and 28 proteins
up-regulated and 87 downregulated in iPSCMNs compared
with ESCMNs. The relatively small number of differentially
expressed proteins did not result in any significant differences
in experimental outcome between these two sources of MN in
vitro or in vivo, suggesting that iPSC-derived MN may indeed
be a suitable alternative to ESCMNs in therapeutic and phar-
maceutical testing applications.
Spatial Aspects of Expression—Subcellular fractionation
followed by MS-based identification allows the detailed study
of cellular compartments. In the context of NSCs, identifica-
tion of secreted proteins may lead to development of better
hypotheses on mechanisms of action whereas identification
of membrane proteins may shed light on potential signaling
cascades and also inform novel means to further purify sub-
populations. Not to ignore the intracellular compartments,
understanding where proteins reside at a certain time also
reveals information on cell states, for instance the sequestra-
tion of transcription factors in the cytoplasm limits physical
access of the transcription factors to regulate transcription in
the nucleus.
A highly supported hypothesis regarding mechanism of
action of stem cells in transplantation is the provision of
trophic factors to the injured environment. Obtaining those
species secreted by NSCs in vitro into the culture medium is
relatively easy but is a challenging proteome to analyze, given
the dynamic range of protein expression and the often nec-
essary addition of serum or supplements to the medium for
normal cell growth, which can further complicate the identifi-
cation of low abundance proteins. One group used an immor-
talized mouse NSC line derived from embryonic mesenceph-
alon in an effort to identify secreted proteins as NSCs
differentiate, first using LC-MS/MS (82) and then with a tar-
geted array of proteins using a multiplexed immunoassay (83).
Using MS, 104 nonredundant proteins were detected such as
secreted protein, acidic, cysteine-rich (SPARC), neural cell
adhesion molecule (NCAM), and pigment epithelium-derived
factor (PEDF), but the list was likely heavily biased toward the
most abundant members of the secretome, which included
fibronectin, vimentin, alpha-actinin, and heat shock protein 90
(HSP90). To address the issues of protein dynamic range,
they then turned to a commercially available targeted multi-
plexed immunoassay to detect expression of 23 cytokines
and chemokines that were predicted to be present at much
lower levels and identified a potential role for the chemokine
(C-C motif) ligand 2 (CCL2 or MCP) in neural differentiation.
Similarly, a commercially available array targeting 507 pro-
teins was used to screen the secretome of a human NSC line
compared with the same line that had been differentiated into
oligodendrocytes by overexpression of the transcription fac-
tor, Olig2 (84). The authors then combined these data with
RNA-seq data from the same populations to discover many
novel ligand-receptor pairs coexpressed by oligodendro-
cytes, such as chemokine (C-X-C motif) receptor 2 (CXCR2)
and its ligands, chemokine (C-X-C motif) ligand (CXCL) 1–3,
CXCL5, CXCL6, and CXCL8, and the interleukin-6 (IL-6) li-
gand and its receptors interleukin-6 receptor (IL6R) and inter-
leukin-6 signal transducer (IL6ST), suggesting autocrine sig-
naling may play a more important role in the differentiation
and maintenance than previously thought. To gain insight into
the temporal aspects of the differentiating secretome, Farina
et al. examined mouse ECSs to those acquiring a cardiac and
a neural fate during early and late commitment and identified
a number of secreted proteins unique to the neurogenic group
such as thrombospodin-1, ezrin, and biglycan (85). A review
of additional secretome studies can be found in (86).
A less well-studied “omics,” lipidomics, is defined as the
large-scale analysis of membrane lipids. Lipids are able to
both directly and indirectly modulate protein function and
consist of several categories, including sphingolipids, glycer-
olipids, glycerophospholipids, fatty acids, and sterols. Lipids
are known to have key roles in NSC biology. For instance,
lysophosphatidic acid is capable of regulating proliferation of
mouse NSCs in a neurosphere model (87) and of the differ-
entiation to neural lineages of human NSCs derived from
ESCs (88). One of the first studies to use advanced, large-
scale MS techniques involved the profiling of retinal stem cells
and demonstrated a retinal stem cell-unique signature com-
pared with non-retinal stem cells (89). This category of mole-
cules clearly has an important role in stem cell biology, yet
there have been very few studies directed at understanding
the landscape of lipids within NSCs. Improvements in lipido-
mics platforms, such as that recently reported by Almeida et
al. to quantitatively identify over 300 lipid species in mouse
brain tissue, may change that (90).
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Temporal Aspects of Expression—One of the pressing is-
sues in the field is the elucidation of molecular routes to
differentiation to better understand the underlying mecha-
nisms of neural development and to better direct cellular
outcomes (reviewed in (67, 91)). In two separate efforts, Chae-
rkady and colleagues studied temporal quantitative changes
in protein expression at eight different time points as human
ESCs were differentiated to neural progenitor cells and into
motor neurons and astrocytes using 8-plex iTRAQ and qua-
drupole time-of-flight (92) and into glial and oligodendrocyte
progenitor lineages using 4-plex iTRAQ and LTQ-Orbitrap
(93). The subsequent identification of over 4,000 proteins
represents a rich source of temporally and lineage-specific
proteins for further study. Focusing on the membrane pro-
teome changes during glial differentiation, Cao et al. used an
immortalized mouse neural stem cell line to identify mem-
brane proteins expressed by the undifferentiated neural stem
cell and following astrocyte differentiation using SILAC label-
ing and LTQ-Orbitrap (94). Out of the more than 700 proteins
identified in this study, 205 were differentially expressed by
1.5-fold or more, with the additional finding that changes in
expression of mitochondrial membrane proteins was associ-
ated with glial differentiation. To demonstrate the power of
combining discovery-based proteomics with multiple reaction
monitoring, Yocum and colleagues studied feeder cell- and
conditioned medium-free human ESCs following the acquisi-
tion of a neural fate via modulation of bone morphogenic
protein signaling (95). Using the iTRAQ platform, quantitative
global protein expression was accomplished using the iTRAQ
platform, followed by multiple reaction monitoring of a selec-
tion of proteins to both validate the global proteomics results
and to quantitate protein isoforms by utilizing isoform-unique
peptides.
With so many groups studying various aspects of stem
cells in general, efforts are underway to facilitate collabora-
tion, and the sharing of data and methodology. The Human
Proteome Organization (HUPO) and the International Soci-
ety for Stem Cell Research (ISSCR) jointly established the
Proteome Biology of Stem Cells Initiative, which serves at
an international level to move the field of stem cell proteom-
ics forward and to promote collaboration among interna-
tional research groups. Online repositories and resources
also exist, each with various strengths and data foci, a few
of which include scor.chem.wisc.edu, proteomicsdb.org,
proteomexchange.org, stemformatics.org, ebi.ac.uk/pride,
and stemcelldb.nih.gov (96). A useful review of major pro-
teomics repositories and databases can be found in (97).
Emerging Technologies—
Software and Bioinformatics—NSCs are increasingly being
defined by a multitude of “omics” approaches—genomic,
transcriptomic, translatomic, and epigenomic as well as pro-
teomic—each with varying degrees of technological maturity.
Proteomics data are often going hand-in-hand with other
larger datasets such as chromatin remodeling, RNA-seq, and
immune profiling to name a few. These large datasets present
both tremendous promise and challenge. Data integration, as
opposed to data addition, becomes an issue for a number of
reasons—not only is the information from each platform
unique, but it also represents distinctive datasets and orga-
nization, containing fundamentally disparate data with differ-
ing limitations, and false discovery rates. Getting these data-
sets data to “talk” requires some level of programming
bridging and is becoming a much more crucial component of
analyses as researchers go beyond the classic single meth-
odology approach. A major tour-de-force effort recently ex-
amined the genome-wide CpG (-C-phosphate-G- regions of
the DNA) methylation and chromatin marks, the transcriptome
(miRNA, lncRNA, mRNA), and the global and cell-surface
quantitative proteome of iPSC reprogramming, the data re-
sulting from which can be found at www.stemformatics.org
through the appropriately named Project Grandiose portal
(98). The means with which to accumulate these large data-
sets for easy public access, along with the tools with which to
query it, continue to be developed. Groups, such as those
behind Stemformatics, are further establishing repositories of
data and tools to facilitate the analysis, visualization, sharing,
and access of stem cell data (99).
Novel Platforms for NSC Research—In addition to the com-
monly used MS-based platforms, there are some novel tech-
niques being developed for targeted proteomic studies that
have yet to be applied to NSCs and present opportunities for
future research. Single-cell mass cytometry makes use of the
combination of stable nonbiological isotope tagged antibod-
ies with inductively coupled plasma mass spectrometry de-
tection, currently allowing over 40 different parameters to be
analyzed simultaneously per cell at a rate of about 500 cells
per second (100). Its potential was recently demonstrated in
the profiling over time of the generation of iPSCs from fibro-
blasts via three separate reprogramming protocols, generat-
ing a single cell comprehensive map of the conversion so-
matic cells to a pluripotent state (101). One of the advantages
to this technique is the single cell resolution, currently chal-
lenging using other mass-spectrometry-based systems,
which is particularly important when mapping out differentia-
tion programs or understanding the heterogeneity in a cell
population.
The generation of high-quality human antibodies through
the efforts of the Human Protein Atlas has moved affinity
proteomics to another level (102, 103). Using highly multi-
plexed antibody bead arrays as means to identify neurological
disease, Bystro¨m et al. systematically screened plasma sam-
ples of patients with multiple sclerosis with over 4,595 anti-
bodies to ultimately focus the effort to the expression of 43
proteins using 101 antibodies on larger numbers of samples
of both plasma and CSF (104). Confirmation of multiple scle-
rosis specific protein expression was made in human post-
mortem tissue and plasma and has provided a number of
potential circulating protein targets and their respective neural
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cell type source. This approach may prove to be powerful in
elucidating mechanisms of action of NSC transplants, al-
though the success of these studies clearly relies heavily on
the quality of the available antibodies and the ability to con-
firm the results using other techniques.
A recently developed technique called comprehensive
identification of RNA-binding proteins by mass spectrometry,
or ChIRP-MS, allows the analysis of the less studied subpro-
teome of RNA-binding proteins (105). Long noncoding RNAs
(lncRNAs) have been shown to have key roles in neural de-
velopment and NSC biology, including the identification of
lncRNAs specific to NSCs in the adult mouse (106) and the
expression of lncRNAs in the differentiation of embryonic
NSCs into neuronal and glial lineages (107). lncRNAs exert
control over transcription via RNA-binding proteins but the
identification of these proteins with high specificity and com-
prehensive coverage has previously been technologically
challenging. ChIRP-MS was used to identify 81 RNA-binding
proteins specific to Xist, an lncRNA involved in X chromosome
inactivation, via extensive crosslinking of the protein–RNA
complex, followed by identification of those binding partners
by LC-MS/MS (105). To identify proteins binding to key tran-
scriptional enhancers, promoters, and chromatin in mouse
ESCs, Engelen et al. used chromatin immunoprecipitation
followed by mass spectrometry, a technique termed ChIP-MS
(108). Using gel chromatography and an LQT-Orbitrap MS,
239 proteins were reported, comprising a rich set of candi-
dates not only to understand the pluripotent state of ESCs but
also to potentially identify new candidates in reprogramming
of somatic cells to iPSCs. There is an opportunity to apply
these approaches to NSCs and their progeny.
Challenges—Are there common NSC-specific themes or
biological pathways that have emerged from the large body of
existing research, including that provided through other tech-
nologies? In the RNA expression array field, this goal seems
elusive (109) and is not likely realistic in the proteomics field,
particularly given the increasingly diverse populations of
NSCs. Indeed, a meta-analysis of published proteomics data
from three unique human ESC lines identified only 32 intra-
cellular and 16 membrane proteins in common (110). Cellular
heterogeneity will continue to be an issue as there are a
myriad of variables present up to the final dataset, including
animal versus human cell sources, diversity of protocols for
isolation, derivation and differentiation, introduction of arti-
facts through the use of feeder cells, or conditioned medium.
Finally, there is a massive library of methodological and in-
strumental choices in the separation, enrichment, identifica-
tion, and analysis steps. MS-based platforms continue to
improve, and future experiments will benefit by further in-
creasing the coverage of the proteome, from a cellular and
subcellular point of view.
As outlined above, there are a variety of cells within the CNS
that can be defined as NSCs. These are different according to
CNS region and developmental timing and even within small
brain regions; there may be multiple cell types that possess
NSC characteristics. Although novel platforms are enabling
enrichment of these NSC types, the yield of these sorting
experiments may be extremely low and require a large amount
of starting tissue to produce enough cellular material for pro-
teomics experiments. Currently, the most common approach
to obtain large quantities of NSCs is to rely on in vitro cultur-
ing. However, this has several drawbacks. In the case of
derivation of NSCs from murine or human CNS, cultures
undergo some degree of spontaneous differentiation, result-
ing in cellular heterogeneity. In fact, the simple act of culturing
NSCs alters their qualities and characteristics by removing
crucial in vivo spatial and temporal cues. As reviewed above,
recent studies have greatly enhanced our ability to obtain
region- and cell-type-specific NSCs from human and murine
pluripotent stem cells. However, these NSCs may be different
from those found in vivo. Furthermore, in vitro cultures require
significant time and expense to reach the point of NSC gen-
eration for proteomic analyses, particularly in the case of
human cells, and all cultures, including those pluripotent stem
cell derived, will be somewhat heterogeneous. The caveats
described above should not preclude proteomics studies of
NSCs but rather suggest that all studies be done with caution
and that all analyses be confirmed using anatomical and
functional methods wherever possible. For example, if a pro-
teomics experiment identifies a protein as being enriched in
cultures of NSC derived from the cerebral cortex, the exper-
imenters may then use immunohistochemistry to evaluate the
localization of that protein in vivo and examine the function in
more detail utilizing knockdown or other means, as we have
reported (57).
The application of proteomics platforms has been crucial to
our growing but incomplete understanding of the complex
dynamics of how NSC fate is directed, how NSCs retain their
potency and ability to self-renew, how NSCs populations
differ, and finally how specific differentiation of NSCs can be
accomplished. Proteomics approaches complement data ob-
tained via other technologies, and it is the combination of
these various datasets, obtained from well-defined popula-
tions of NCSs, that will continue to move the field ahead. The
next stage of NSCs proteomics will require a multidisciplinary
approach, combining the interests of biochemists, neurosci-
entists, and bioinformatics experts, and will allow proteomics
studies to move from being technical achievements of interest
to being a part of the routine armamentarium of those study-
ing NSC cell biology, much as has occurred with studies of
genomics and mRNA expression a few decades ago.
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